Overview

A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Status:
Completed

Trial end date:
2016-08-16

Target enrollment:

Participant gender:

Summary

The purpose of this study was to determine the efficacy and safety of intravenous cefiderocol (S-649266) in hospitalized adults with complicated urinary tract infections caused by Gram-negative pathogens.

Phase:

Phase 2

Details

Lead Sponsor:

Shionogi

Treatments:

Cilastatin
Imipenem